# Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy

> **NCT07529938** · — · COMPLETED · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 222 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy (HCM)
- Obstructive Hypertrophic Cardiomyopathy (oHCM)

## Interventions

- **DRUG:** mavacamten

## Key facts

- **NCT ID:** NCT07529938
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07529938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07529938, "Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07529938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*